HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 30 November 2015

Cochrane Collaboration Issue 11, 2015

Issue 11 is almost complete.  It includes dozens of new or updated reviews, including:
  • Anti-TNF agents for paediatric psoriasis
  • Asenapine versus placebo for schizophrenia
  • Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission
  • Omega-3 fatty acids for depression in adults
  • Omega 6 fatty acids for the primary prevention of cardiovascular disease
  • Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children
  • Vigabatrin versus carbamazepine monotherapy for epilepsy
  •  Interventions for the treatment of keratocystic odontogenic tumours